Skip to content
10-Q

Quarterly Report

Hepion Pharmaceuticals, Inc. CTRVP HEPA

0001493152-25-021864

← back to feed
Filed
Nov 12, 2025 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2025 · Nov 12, 2025 11.62M sh
Shares Diluted Q3 2025 · Sep 30, 2025 11.62M sh
Shares Diluted Q3 2025 · Sep 30, 2025 8.65M sh
Shares Diluted restated Q3 2025 · Sep 30, 2024 134.38K sh
Shares Diluted restated Q3 2025 · Sep 30, 2024 117.41K sh
Operating Cash Flow Q3 2025 · Sep 30, 2025 −$2.94M
Operating Cash Flow Q3 2025 · Sep 30, 2024 −$17.06M
Stockholders Equity Q3 2025 · Sep 30, 2025 $3.32M
Stockholders Equity Q3 2025 · Jun 30, 2025 $3.8M
Stockholders Equity Q3 2025 · Mar 31, 2025 $3.9M
Stockholders Equity Q3 2025 · Dec 31, 2024 −$1.86M
Stockholders Equity restated Q3 2025 · Sep 30, 2024 $406.69K
Stockholders Equity Q3 2025 · Jun 30, 2024 $3.56M
Stockholders Equity Q3 2025 · Mar 31, 2024 $7.52M
Stockholders Equity Q3 2025 · Dec 31, 2023 $7.28M
Current Liabilities Q3 2025 · Sep 30, 2025 $347.41K
Current Liabilities Q3 2025 · Dec 31, 2024 $3.14M
Total Liabilities Q3 2025 · Sep 30, 2025 $415.81K
Total Liabilities Q3 2025 · Dec 31, 2024 $3.48M
Current Assets Q3 2025 · Sep 30, 2025 $3.74M
Current Assets Q3 2025 · Dec 31, 2024 $1.61M
Total Assets Q3 2025 · Sep 30, 2025 $3.74M
Total Assets Q3 2025 · Dec 31, 2024 $1.61M
Eps Diluted Q3 2025 · Sep 30, 2025 −$0.04
Eps Diluted Q3 2025 · Sep 30, 2025 −$0.88
Eps Diluted restated Q3 2025 · Sep 30, 2024 −$36.21
Eps Diluted restated Q3 2025 · Sep 30, 2024 −$99.18
Eps Basic Q3 2025 · Sep 30, 2025 −$0.04
Eps Basic Q3 2025 · Sep 30, 2025 −$0.88
Eps Basic restated Q3 2025 · Sep 30, 2024 −$36.21
Eps Basic restated Q3 2025 · Sep 30, 2024 −$99.18
Sga Expense Q3 2025 · Sep 30, 2025 $527.9K
Sga Expense Q3 2025 · Sep 30, 2025 $2.71M
Sga Expense Q3 2025 · Sep 30, 2024 $1.7M
Sga Expense Q3 2025 · Sep 30, 2024 $5.71M
Rd Expense Q3 2025 · Sep 30, 2025 $445.51K
Rd Expense Q3 2025 · Sep 30, 2024 $2.76M
Rd Expense Q3 2025 · Sep 30, 2024 $12.44M
Net Income Q3 2025 · Sep 30, 2025 −$472.51K
Net Income Q3 2025 · Sep 30, 2025 −$7.62M
Net Income Q3 2025 · Jun 30, 2025 −$1.04M
Net Income Q3 2025 · Mar 31, 2025 −$6.11M
Net Income Q3 2025 · Sep 30, 2024 −$4.87M
Net Income Q3 2025 · Sep 30, 2024 −$11.64M
Net Income Q3 2025 · Jun 30, 2024 −$3.93M
Net Income Q3 2025 · Mar 31, 2024 −$2.85M
Operating Income Q3 2025 · Sep 30, 2025 −$527.9K
Operating Income Q3 2025 · Sep 30, 2025 −$3.55M
Operating Income Q3 2025 · Sep 30, 2024 −$4.46M
Operating Income Q3 2025 · Sep 30, 2024 −$18.14M